<DOC>
	<DOCNO>NCT01799460</DOCNO>
	<brief_summary>The purpose study analysis different genotype idiopathic membranous nephropathy patient different therapeutic outcome treat Comprehensive Treatment Regimen immunosuppressive agent , look ideal marker assess appropriate treatment approach long-term efficacy .</brief_summary>
	<brief_title>Study Single-nucleotide-polymorphism Idiopathic Membranous Nephropathy</brief_title>
	<detailed_description>The primary objective study look gene level predictor patient suffer idiopathic membranous nephropathy . And accord predictor , clinician could make decision method take IMN patient , Traditional Chinese Medicine western medicine , could get good result .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , Membranous</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Immunosuppressive Agents</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<criteria>Clinical diagnosis idiopathic membranous nephropathy Chronic Kidney Disease ( CKD ) ≤3 stage（Glomerular Filtration Rate ( GFR ) ≥30ml/min）and 24 hour urinary protein≥3g Voluntarily participate study sign informed consent Combined lifethreatening complication serious infection Abnormal glucose metabolism Patients malignant tumor malignancy , HIV infection history mental illness , acute central nervous system disease , serious gastrointestinal disease , etc Pregnancy breastfeed woman Undergoing clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>single-nucleotide-polymorphism</keyword>
	<keyword>Traditional Chinese Medicine</keyword>
	<keyword>Comprehensive Treatment Regimen</keyword>
</DOC>